Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis - Wikidata - wikimedia - TriplyDB

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

http://www.wikidata.org/entity/Q36780787

about

The Calcium-Sensing Receptor and Integrins in Cellular Differentiation and Migration Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim The ZNF304-integrin axis protects against anoikis in cancer The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues.Therapeutic value of quinazoline-based compounds in prostate cancer.Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo.Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels A cell-ECM screening method to predict breast cancer metastasis.Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.The pleiotropic role of exchange protein directly activated by cAMP 1 (EPAC1) in cancer: implications for therapeutic intervention.Ligand-independent activation of MET through IGF-1/IGF-1R signaling.Rab11 and Lysotracker Markers Reveal Correlation between Endosomal Pathways and Transfection Efficiency of Surface-Functionalized Cationic Liposome-DNA Nanoparticles.Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.Loss of Dlg5 expression promotes the migration and invasion of prostate cancer cells via Girdin phosphorylation.Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".Exogenous SPARC suppresses proliferation and migration of prostate cancer by interacting with integrin β1.Inhibition of KPNA4 attenuates prostate cancer metastasis.CDK5 in oncology: recent advances and future prospects.P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.Integrin Inhibitors in Prostate Cancer.β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.Avicequinone B sensitizes anoikis in human lung cancer cells.

P2860

Q26746018-C650CA61-E85D-40BB-B5BC-A93D48228894 Q27322913-3301516E-F94F-4BDA-9FFB-1B3B572CF733 Q28115264-E1A04F61-8801-48E4-84B2-4644D93DED19 Q28118861-98D3D04B-C214-4A48-9D24-F9DCC12CE383 Q30357469-0525CF7A-4522-4738-AD98-F2CD5C71908D Q33746225-1DA3F9DA-2F2D-48B1-91C8-B156A56F4A03 Q34447181-A4FB8B97-C5EC-4066-A69A-708E21DA809C Q34459348-ADB2CEED-5CA8-43A1-A769-66E6DC59DA4D Q35018529-24165EAB-B4F4-47F0-9B70-615DEE3A9EF2 Q35070945-F10A28F9-98FF-457E-A976-708B6A8FDB4C Q35832949-F7244A17-6A8E-456E-A3AC-F53347F5C8C4 Q36398745-9F102B2B-136C-46FC-B316-4DF612EA21B3 Q37018397-DCD6E30C-FF6E-4167-9D6B-743AC1FEE9F8 Q37075241-C427F1D0-F71C-4269-BC17-B5E6DB3ED0D5 Q38822335-5A0C1E2D-8C2E-4065-884F-9F09F5B39A6A Q38824206-30215901-7589-48DE-9493-F9CEEAAF7FEE Q39012294-49962EAD-4713-4CE5-931F-748DCF72E953 Q39028687-5569AD3A-89FC-4C88-BA0C-C1CFDA4B9B42 Q40087550-587C7C95-0BCA-42F7-859D-8150C02CD362 Q41114317-DFCD0820-EF76-4A20-A92B-E4B4F62CF8DD Q41636608-646899A7-05BB-48B4-A1CB-4707845B181D Q41871186-F8C92C60-A76F-4F04-B836-C6EE95C2ADEB Q42317547-ADA17DBC-53D2-4846-BEE4-65DD3E0CA9F6 Q44504681-16B8531B-D6BC-4919-976A-1177D767B2B6 Q46797418-5E1DE69E-1D18-4538-81A4-D57D71D68FDB Q47873426-C030471D-4826-4B7C-A585-71FC4C8CD3EE Q48213528-FB274D84-948F-4D13-A406-E7C92A4A6DE0 Q50132111-513157BB-C700-4673-8DF2-7CCCB6323436 Q52647715-47EC815D-C849-47DE-808F-AFC934308D08 Q54116883-8DFF0097-0AF8-43CB-B963-86AE13991393

P2860

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

http://www.wikidata.org/entity/Q36780787

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

@ast

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

@en

type

label

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

@ast

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

@en

prefLabel

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

@ast

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

@en

P1433

Q36780787-86ECC44A-3CCF-4C02-A01F-CB4BB15062AE

P1476

Q36780787-F8454C5B-F519-4936-835B-1C76A8BE2447

P2093

Q36780787-1F5D7931-A8B5-4257-89FB-A97FC92AA35E

Q36780787-43A4913D-0A8B-4D47-A028-19AFE3C12746

Q36780787-455C3C46-17E6-4AE9-AE27-2CA738708379

Q36780787-4F04C704-976D-49F4-9329-CAA9FE0B943F

Q36780787-54BDD9EF-421B-462D-8E29-5CCD0B57D4F4

Q36780787-5F0C25F8-0D40-4297-A3A9-52CBA3DD7215

Q36780787-6088007D-F8D3-47B4-B8E3-8775CD20BA47

Q36780787-6B1BEC8A-6E66-426B-A5C8-BF808A3C92AA

Q36780787-6BA22994-1A13-4550-B749-415B022B2734

Q36780787-738EDE46-34E5-4F4D-A814-14AEA888BC49

P2860

Q36780787-00706183-66CB-4597-A521-319EA4BF5BA4

Q36780787-009590D6-6794-43C0-8493-DAA34018FB98

Q36780787-02CD7C26-D810-4804-A0B2-2F859F1B534B

Q36780787-0856FA3F-92B4-4854-9525-8E0394AFAAAD

Q36780787-09E8AAF3-05DA-40A3-9B62-DF0D7AE337C1

Q36780787-10916F10-4FDF-4D6F-AA3B-E95AA1338FC3

Q36780787-12C5F87D-211A-4026-B37D-230FE2CFB993

Q36780787-12FBCDA7-C71A-449B-9044-E9868FD74BA7

Q36780787-2194163A-9238-4BA7-97AE-FBF64B9FB75B

Q36780787-2752A2E4-39C5-4CF8-911F-7283C601EDE8

P304

Q36780787-F62286DB-71C1-427B-A81D-A6900D1B6AEF

P31

Q36780787-5A177DFF-012E-4B2D-BFB7-189BED458B91

P356

Q36780787-C773EB37-164E-4301-A87B-39E63B87C3D4

P433

Q36780787-064AB21D-15D8-4AF3-8461-BFA54DE79C20

P478

Q36780787-3722E170-54E4-45BB-91DB-7887A238AA1C

P577

Q36780787-5F74D5E3-8585-4DE3-AC48-DB4EC01EF658

P5875

Q36780787-75B070E2-B551-4B0A-8803-F629216B754D

P698

Q36780787-CF3D7D30-E287-4D62-BD6D-FB40686CF0EE

P932

Q36780787-6F1BA2DA-40D5-4291-A890-A4C618B55A30

P356

1541-7786.MCR-12-0551

P1433

Molecular Cancer Research

P1476

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis

@en

P2093

Bradley W McIntyre

http://www.w3.org/2001/XMLSchema#string

Chien-Jui Cheng

http://www.w3.org/2001/XMLSchema#string

Chih-Fen Huang

http://www.w3.org/2001/XMLSchema#string

Christopher J Logothetis

http://www.w3.org/2001/XMLSchema#string

Edward T Yeh

http://www.w3.org/2001/XMLSchema#string

Gary E Gallick

http://www.w3.org/2001/XMLSchema#string

Jian H Song

http://www.w3.org/2001/XMLSchema#string

Jung-Kang Jin

http://www.w3.org/2001/XMLSchema#string

Li-Yuan Yu-Lee

http://www.w3.org/2001/XMLSchema#string

Miao Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-integrin monoclonal antibodies

Integrins: bidirectional, allosteric signaling machines

Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98

Integrin signaling

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Alternatively spliced variants: a new view of the integrin cytoplasmic domain

Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion

Dissemination and growth of cancer cells in metastatic sites

Metastasis: from dissemination to organ-specific colonization

Systemic spread is an early step in breast cancer

P304

405-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-12-0551

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234824605

http://www.w3.org/2001/XMLSchema#string

P698

23339185

http://www.w3.org/2001/XMLSchema#string

P932

3631285

http://www.w3.org/2001/XMLSchema#string